Last updated on February 2018

Long-term QoL in Acute Promyelocytic Leukemia Treated With ATO or Standard Chemotherapy


Brief description of study

This is a prospective and international observational study run by the GIMEMA. All data will be centrally collected and analyzed at the GIMEMA Data Center in Rome (Italy). Patients reported outcomes will be collected using internationally validated questionnaires.

Clinical Study Identifier: NCT03096496

Find a site near you

Start Over